Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle

Azacitidine is a DNA methyltransferase inhibitor that has been used as a singular agent for the treatment of myelodysplastic syndrome-refractory anemia with excess blast-1 and -2 (MDS-RAEB I/II). However, recurrence and overall response rates following this treatment remain unsatisfactory. The combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaobo, Yuan, Lihua, Lu, Bo, Lin, Dongjun, Xu, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652243/
https://www.ncbi.nlm.nih.gov/pubmed/38023359
http://dx.doi.org/10.3892/etm.2023.12274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652243/
https://www.ncbi.nlm.nih.gov/pubmed/38023359
http://dx.doi.org/10.3892/etm.2023.12274

Ejemplares similares